SOP for Ensuring Compliance with US FDA Stability Testing Requirements

Guidelines for Compliance with US FDA Stability Testing Requirements

1) Purpose

The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for ensuring compliance with US FDA stability testing requirements for drug substances and drug products. This SOP ensures that all stability studies meet the regulatory expectations for the US market.

2) Scope

This SOP applies to all personnel involved in the design, execution, and documentation of stability studies for drug substances and drug products intended for the US market.

3) Responsibilities

Stability Testing Team: Responsible for conducting stability studies and documenting results in compliance with US FDA guidelines.

Quality Assurance (QA) Team: Responsible for reviewing and approving stability study protocols and reports.

Regulatory Affairs Team: Responsible for ensuring that stability studies meet the regulatory requirements of the US FDA.

4) Procedure

4.1 Preparation for Stability Testing

4.1.1 Obtain and review the latest US FDA guidelines for stability

testing of drug substances and drug products.

4.1.2 Identify the product to be tested and determine the type of stability study required (e.g., long-term, accelerated, or intermediate).

4.1.3 Develop a stability protocol that includes study design, testing schedule, storage conditions, and testing parameters as per US FDA guidelines.

4.2 Selection of Batches and Samples

4.2.1 Select

representative batches of the product, typically three primary batches manufactured using the proposed production process.

4.2.2 Prepare sufficient samples to cover the entire study duration, considering the number of time points and tests to be conducted.

4.3 Defining Storage Conditions and Time Points

4.3.1 Define the storage conditions according to US FDA guidelines, typically including:

Long-term stability: 25°C ± 2°C/60% RH ± 5% RH
Accelerated stability: 40°C ± 2°C/75% RH ± 5% RH
Intermediate stability (if needed): 30°C ± 2°C/65% RH ± 5% RH

4.3.2 Establish the time points for sampling, such as 0, 3, 6, 9, 12, 18, and 24 months for long-term studies, and additional time points for accelerated studies.

4.4 Conducting Stability Tests

4.4.1 Store samples under the defined conditions, monitoring temperature and humidity to ensure compliance with the set parameters.

4.4.2 At each specified time point, remove samples and conduct stability-indicating tests, including physical, chemical, microbiological, and functional tests, as applicable.

4.4.3 Record all results meticulously in stability data sheets, ensuring accuracy and traceability of data.

5) Abbreviations, if any

US FDA: United States Food and Drug Administration
QA: Quality Assurance

6) Documents, if any

Stability protocol, stability data sheets, stability testing records, stability report, submission package to US FDA.

7) Reference, if any

US FDA Guidance for Industry: Stability Testing of New Drug Substances and Products.

8) SOP Version

Version 1.0